Sees FY24 adjusted EBITDA $20M-$23M.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AQST:
- Aquestive Therapeutics Optimistic Financial and Strategic Outlook
- Aquestive Therapeutics, Inc. (AQST) Q3 Earnings Cheat Sheet
- Aquestive to present subsequent analysis of data from Anaphylm study
- Aquestive announces primary, secondary endpoints met in OAS challenge study
- Aquestive Therapeutics’ Breakthrough in Allergy Treatment Study